Comparative Registry of the PROmus™, ENdeavor™ and CYpher™ Drug Eluting Stents
NCT00930878 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1934
Last updated 2017-02-03
Summary
The purpose of this study is to collect real-life data of the Promus™ stent, the Cypher™ stent and the Endeavor™ stent in routine clinical practice, and compare outcomes.
Conditions
- Percutaneous Coronary Intervention
Interventions
- DEVICE
-
Cardiac Stenting
Drug Eluting stent
Sponsors & Collaborators
-
Boston Scientific Corporation
lead INDUSTRY
Principal Investigators
-
Christian Hamm, MD · Kerckhoff-Klinik GmbH
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- Germany
Study Locations
More Related Trials
-
Carotid Revascularization With MicroNet Covered Stent Comparing Early Neurological Outcomes With Distal Versus Proximal EPS
NCT05257161 ·Status: RECRUITING ·Phase: NA
-
CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)
NCT00245401 ·Status: COMPLETED ·Phase: PHASE4
-
RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population
NCT00752128 ·Status: COMPLETED
-
Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting
NCT04900844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems
NCT00715884 ·Status: UNKNOWN ·Phase: NA
-
EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus
NCT02632292 ·Status: TERMINATED ·Phase: NA
-
Adapt Monorail Carotid Stent System: A Postmarket Clinical Follow-up Study
NCT01133327 ·Status: COMPLETED ·Phase: NA
-
TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?
NCT00344630 ·Status: COMPLETED ·Phase: NA
-
The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus
NCT00235092 ·Status: COMPLETED ·Phase: PHASE4
-
High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)
NCT07166731 ·Status: RECRUITING
-
Randomized Comparison of Catheter-based Strategies for Interventional Access Site Closure During Transfemoral Transcatheter Aortic Valve Implantation
NCT04459208 ·Status: COMPLETED ·Phase: NA
-
Gangwon PCI Prospective Registry
NCT02038127 ·Status: RECRUITING
-
Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent
NCT01336101 ·Status: COMPLETED ·Phase: NA
-
Assessment of Clinical Performance and Costs of the Endeavor Resolute Stent "in Real Life" in Spain.
NCT00850213 ·Status: COMPLETED
-
Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)
NCT00231231 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease
NCT00640770 ·Status: COMPLETED ·Phase: PHASE4
-
Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)
NCT01526811 ·Status: COMPLETED
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
NCT05378347 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the 3-in-1 Neuroguard IEP System for Carotid Artery Stenosis
NCT04142541 ·Status: COMPLETED ·Phase: NA
-
Edwards Cardioband European Post-Market Study, MiBAND
NCT03600688 ·Status: UNKNOWN
-
Endurant Bifurcated and Aorto-Uni-Iliac (AUI) Stent Graft System
NCT00705718 ·Status: COMPLETED ·Phase: NA
-
eTryton Left Main Registry Tryton Side Branch Stent® Tmt of Denovo CAD in LM and CFX Arteries
NCT02765646 ·Status: UNKNOWN
-
French Post-Marketing Surveillance Survey
NCT00855478 ·Status: TERMINATED ·Phase: PHASE4
-
Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent
NCT04138238 ·Status: COMPLETED
-
Prospective Evaluation of Safety and Efficacy Vertebral Drug-eluting Stent System
NCT02328781 ·Status: COMPLETED ·Phase: NA